Ipca Labs will be in focus today as the USFDA lists serious deviations on Ratlam API facility. Archana Shukla has more details.
Ipca Labs will be in focus today as the USFDA lists serious deviations on Ratlam API facility. Archana Shukla has more details.
Ipca Labs stock price
On August 08, 2014, at 09:20 hrs Ipca Laboratories was quoting at Rs 678.00, down Rs 46.85, or 6.46 percent. The 52-week high of the share was Rs 906.90 and the 52-week low was Rs 609.00.
The company's trailing 12-month (TTM) EPS was at Rs 43.67 per share as per the quarter ended March 2014. The stock's price-to-earnings (P/E) ratio was 15.53. The latest book value of the company is Rs 157.02 per share. At current value, the price-to-book value of the company is 4.32.
Anda sedang membaca artikel tentang
USFDA lists deviations on Ipca Labs' Ratlam API unit
Dengan url
http://sehatkafein.blogspot.com/2014/08/usfda-lists-deviations-on-ipca-labs.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
USFDA lists deviations on Ipca Labs' Ratlam API unit
namun jangan lupa untuk meletakkan link
USFDA lists deviations on Ipca Labs' Ratlam API unit
sebagai sumbernya
0 komentar:
Posting Komentar